1. emilyjaneclare
2. feruizdeluna
3. sandan331105
4. pigseye83
5. pcarter075
1.pigseye83 03/26/2018
Loxo Oncology Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancer
2.pcarter075 05/17/2018
Shares rallying nicely
3.emilyjaneclare 03/26/2018
Bayer Announces Completion of Rolling Submission of New Drug Application in the U.S. for Larotrectinib for the Treatment of TRK Fusion Cancer
4.sandan331105 04/10/2018
Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
5.feruizdeluna 05/17/2018
GREEEN
6.feruizdeluna 04/04/2018
Loxo Oncology Announces Acceptance of LOXO-292 Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
7.feruizdeluna 02/21/2018
Alert
8.emilyjaneclare 03/02/2018
Loxo Oncology Reports Fourth Quarter and Year-End 2017 Financial Results
9.feruizdeluna 02/22/2018
Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW